Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Bangladesh
  4. Dhaka Stock Exchange
  5. Beximco Pharmaceuticals Limited
  6. Summary
    BXPHARMA   BD0453BXPH04

BEXIMCO PHARMACEUTICALS LIMITED

(BXPHARMA)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Dhaka Stock Exchange
11/28/2021 11/29/2021 11/30/2021 12/01/2021 12/02/2021 Date
205.7 200.4 192.5 205.8 209.1 Last
528607 1778562 2507023 787401 1073386 Volume
-3.65% -2.58% -3.94% +6.91% +1.60% Change
Estimated financial data (e)
Sales 2022 33 384 M 394 M 394 M
Net income 2022 5 720 M 67,5 M 67,5 M
Net Debt 2022 6 285 M 74,2 M 74,2 M
P/E ratio 2022 16,3x
Yield 2022 1,87%
Sales 2023 37 754 M 446 M 446 M
Net income 2023 6 422 M 75,8 M 75,8 M
Net Debt 2023 3 292 M 38,8 M 38,8 M
P/E ratio 2023 14,5x
Yield 2023 2,06%
Capitalization 93 282 M 1 099 M 1 101 M
EV / Sales 2022 2,98x
EV / Sales 2023 2,56x
Nbr of Employees 5 500
Free-Float 94,3%
More Financials
Company
Beximco Pharmaceuticals Limited (BPL) is engaged in the manufacturing and marketing of generic pharmaceuticals formulation products, including intravenous fluids and active pharmaceutical ingredients (APIs). The Company also provides contract manufacturing services. The Company produces approximately 300 generic medicines, which are available in over 500 different presentations and the portfolio encompasses various... 
Sector
Pharmaceuticals
Calendar
12/22 | 11:30pmShareholder meeting
More about the company
Ratings of Beximco Pharmaceuticals Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about BEXIMCO PHARMACEUTICALS LIMITED
04:53aBeximco Receives COVID-19 Shots for Distribution in Bangladesh
MT
11/24Beximco Says No Confirmation from Serum Institute on Resumption of COVID-19 Vaccine Del..
MT
11/23BEXIMCO PHARMACEUTICALS LIMITED : Ex-dividend day for final dividend
FA
11/11Beximco Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended Se..
CI
11/09Bangladesh's Beximco to sell first generic version of Merck COVID-19 pill
RE
11/09Beximco Unveils Generic Version of Merck & Co.'s COVID-19 Drug in Bangladesh
MT
11/09Beximco Pharmaceuticals Limited Introduces World's First Generic Molnupiravir, an Oral ..
CI
11/02Beximco Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 3..
CI
10/24Beximco Pharmaceuticals Limited Recommends Dividend for the Year Ended on June 30, 2021
CI
10/11BEXIMCO PHARMACEUTICALS : Receives Next Shipment For COVID-19 Vaccine To Distribute To Ban..
MT
10/01BEXIMCO PHARMACEUTICALS : Wraps Up Majority Stake Acquisition In Sanofi Bangladesh
MT
09/03BEXIMCO PHARMACEUTICALS : Wins Bangladesh Bank's Approval for Acquisition of Majority Stak..
MT
08/26BEXIMCO PHARMACEUTICALS : in Talks with Bangladesh, India's Serum Institute on COVID-19 Va..
MT
07/26BEXIMCO PHARMACEUTICALS : Wins US FDA Nod For Muscle Relaxant Drug
MT
07/26Beximco Pharmaceuticals Limited Receives US Food and Drug Administration Approval for B..
CI
More news
News in other languages on BEXIMCO PHARMACEUTICALS LIMITED
04:53aBeximco reçoit des doses de COVID-19 pour la distribution au Bangladesh
11/09Beximco dévoile la version générique du médicament COVID-19 de Merck & Co. au Banglades..
10/24Beximco Pharmaceuticals Limited recommande le versement d'un dividende pour l'exercice ..
10/11Beximco Pharmaceuticals reçoit la prochaine livraison du vaccin COVID-19 pour le distri..
2020Beximco Pharmaceuticals Limited annonce un dividende pour l'exercice clos le 30 juin 20..
More news
Chart BEXIMCO PHARMACEUTICALS LIMITED
Duration : Period :
Beximco Pharmaceuticals Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus SELL
Number of Analysts 2
Last Close Price 209,10 BDT
Average target price 153,00 BDT
Spread / Average Target -26,8%
EPS Revisions
Managers and Directors
Nazmul Hassan Chief Executive Officer, Director & MD
Ali Nawaz Chief Financial Officer
Ahmed Sohail Fasihur Rahman Chairman
Selina Akter Executive Director-Medical Affairs Department
Rabbur Reza Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BEXIMCO PHARMACEUTICALS LIMITED9.76%1 082
JOHNSON & JOHNSON0.44%416 161
ROCHE HOLDING AG18.38%343 323
PFIZER, INC.48.55%306 912
NOVO NORDISK A/S66.91%247 444
ELI LILLY AND COMPANY47.55%225 859